Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
May 2017—Becton Dickinson announced that its BD Veritor System Flu A+B, a digital immunoassay for the rapid detection of influenza, meets the new FDA performance requirements in which antigen-based rapid influenza virus antigen detection systems (RIDTs) intended to detect influenza virus directly from clinical specimens have been reclassified from class I devices to class II devices subject to special controls.
May 2017—Biodesix announced that its GeneStrat test, a liquid biopsy for patients with cancer, now includes ROS1 and RET. GeneStrat is a noninvasive blood test analyzing circulating tumor DNA and RNA. The test provides highly sensitive results in 72 hours for non-small cell lung cancer patients.
May 2017—Meridian has developed anti-müllerian hormone antibodies produced in chickens using a synthetic peptide representing a linear epitope on the human AMH protein. Initial purification of total IgY from eggs was followed by affinity purification against the peptide as an immunogen to yield a monospecific antibody. All antibodies can be used in ELISA.
May 2017—Sarstedt expanded its line of Multiply-µStrip PCR tubes to include a white option for qPCR. The reflective white wells maximize fluorescent signal intensity, minimize cross-talk, and enable volume reduction of expensive reagents without compromising sensitivity or stability.
May 2017—Streck and GenomePrecision Technology, an integrated molecular diagnostics distributor in China, have signed a distribution agreement for Streck’s cell stabilization, molecular, urinalysis, and flow cytometry products.
May 2017—Accelerate Diagnostics announced that the FDA has granted the de novo request to market the Accelerate Pheno system and Accelerate PhenoTest BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples.
May 2017—Inova Diagnostics announced that the FDA has granted 510(k) clearance for its Nova Lite DAPI ANCA (ethanol) and Nova Lite DAPI ANCA (formalin) kits for use with Nova View, a digital IFA microscope. Nova Lite DAPI ANCA kits detect anti-neutrophil cytoplasmic antibodies on an automated digital IFA microscope.
May 2017—Randox has launched Acusera 24.7 Live Online 2.0, which is faster than the previous version, has a simplified user interface, and an enhanced user experience. The biggest update to version 2, according to a company statement, is the ability to review peer data in real time, which enhances troubleshooting capabilities and allows labs to identify trends.
May 2017—Veracyte will extend access to its Afirma Gene Expression Classifier through an agreement with Quest Diagnostics. The agreement is intended to meet growing physician demand for innovative genomic testing services to improve thyroid cancer diagnosis.
May 2017—EntroGen has launched two sample quality assessment products to determine the quantity and quality of DNA samples prior to running downstream qPCR and NGS experiments. The DNA Fragmentation Quantification Assay and Library Quantification Kit for Illumina save samples, time, and reagents by implementing quality control steps before preparing libraries, loading a flow cell for sequencing, and setting up a qPCR or NGS assay. Both assays rely on real-time PCR technology and require a real-time PCR instrument capable of detecting FAM and VIC.
